Home/Pipeline/Deep TMS

Deep TMS

Adolescent Depression

Clinical ResearchDevelopment

Key Facts

Indication
Adolescent Depression
Phase
Clinical Research
Status
Development
Company

About BrainsWay

BrainsWay is a commercial-stage medical device company with a mission to boldly advance neuroscience to improve health and transform lives. Its core achievement is the development and FDA clearance of its Deep TMS platform for multiple psychiatric indications, establishing it as a leader in noninvasive neuromodulation. The company's strategy focuses on expanding its cleared indications, optimizing treatment protocols, and growing its global installed base through direct sales and strategic partnerships. BrainsWay leverages a robust body of clinical evidence to drive adoption among providers and payers.

View full company profile

Other Adolescent Depression Drugs

DrugCompanyPhase
NeuroStar Advanced TherapyNeuroneticsClinical Development